Nuvation Bio (NUVB) director gets 123,397 stock options at $4.79
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nuvation Bio Inc. director Robert B. Bazemore received a stock option grant covering 123,397 shares of Class A common stock. The option has an exercise price of $4.79 per share and expires on May 20, 2036. All shares vest 100% on the earlier of May 21, 2026, or the next shareholder annual meeting, subject to his continuous service. This is a compensation-related award, with no open-market share purchases or sales reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bazemore Robert B
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 123,397 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 123,397 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 123,397 shares
Exercise price: $4.79 per share
Shares underlying option: 123,397 shares
+3 more
6 metrics
Option grant size
123,397 shares
Stock Option (Right to Buy) granted to director
Exercise price
$4.79 per share
Exercise price of stock option
Shares underlying option
123,397 shares
Class A Common Stock underlying the option
Expiration date
May 20, 2036
Option expiration
Vesting date trigger
May 21, 2026 or next annual meeting
100% vesting, subject to continuous service
Post-transaction derivative holdings
123,397 options
Total options held after this grant
Key Terms
Stock Option (Right to Buy), Class A Common Stock, Grant, award, or other acquisition, exercise price, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 4.7900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"subject to the Reporting Person's continuous service through such applicable vesting date"
FAQ
What insider transaction did Nuvation Bio (NUVB) report for Robert B. Bazemore?
Nuvation Bio reported a stock option grant to director Robert B. Bazemore. He received options for 123,397 shares of Class A common stock as a compensation-related award, not an open-market purchase or sale.
What is the exercise price and expiration date of Bazemore’s NUVB option grant?
The option has an exercise price of $4.79 per share and expires on May 20, 2036. This means Bazemore can buy shares at $4.79 anytime before the expiration, once the option is vested.
When do Robert B. Bazemore’s Nuvation Bio (NUVB) options vest?
All 123,397 option shares vest 100% on the earlier of May 21, 2026, or the next shareholder annual meeting. Vesting is conditional on Bazemore’s continuous service with Nuvation Bio through the applicable vesting date.